Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A Dowell

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Journal of Clinical Pharmacology|November 18, 2005
Safety and pharmacokinetics of coadministered voriconazole and anidulafunginJames A Dowell, Jennifer Schranz, Alice Baruch, et al.
Clinical Therapeutics|September 11, 2007
Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney diseaseWilliam B Smith, James A Dowell, Raymond D Pratt
Analytical Chemistry|August 6, 2008
Comparison of two-dimensional fractionation techniques for shotgun proteomicsJames A Dowell, Dustin C Frost, Jiang Zhang, et al.
Journal of Clinical Pharmacology|February 27, 2007
Lack of pharmacokinetic interaction between anidulafungin and tacrolimusJames A Dowell, Martin Stogniew, David Krause, et al.
Antimicrobial Agents and Chemotherapy|August 3, 2022
Safety and Pharmacokinetics of Taniborbactam (VNRX-5133) with Cefepime in Subjects with Various Degrees of Renal ImpairmentJames A Dowell, Thomas C Marbury, William B Smith, et al.
Journal of Proteome Research|June 30, 2015
Quantification of SAHA-Dependent Changes in Histone Modifications Using Data-Independent Acquisition Mass SpectrometryKimberly A Krautkramer, Lukas Reiter, John M Denu, et al.
Journal of Neurochemistry|September 20, 2013
c-Jun N-terminal kinase regulates mGluR-dependent expression of post-synaptic FMRP target proteinsTravis L Schmit, James A Dowell, Margaret E Maes, et al.
Journal of Clinical Pharmacology|January 14, 2005
Assessment of the safety and pharmacokinetics of anidulafungin when administered with cyclosporineJames A Dowell, Martin Stogniew, David Krause, et al.
ACS Omega|February 8, 2021
Benchmarking Quantitative Performance in Label-Free ProteomicsJames A Dowell, Logan J Wright, Eric A Armstrong, et al.
Journal of Clinical Pharmacology|July 18, 2008
Pharmacokinetic-pharmacodynamic modeling of dalbavancin, a novel glycopeptide antibioticJames A Dowell, Beth P Goldstein, Mary Buckwalter, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of Clinical Pharmacology|November 18, 2005
Safety and pharmacokinetics of coadministered voriconazole and anidulafunginJames A Dowell, Jennifer Schranz, Alice Baruch, et al.
Clinical Therapeutics|September 11, 2007
Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney diseaseWilliam B Smith, James A Dowell, Raymond D Pratt
Analytical Chemistry|August 6, 2008
Comparison of two-dimensional fractionation techniques for shotgun proteomicsJames A Dowell, Dustin C Frost, Jiang Zhang, et al.
Journal of Clinical Pharmacology|February 27, 2007
Lack of pharmacokinetic interaction between anidulafungin and tacrolimusJames A Dowell, Martin Stogniew, David Krause, et al.
Antimicrobial Agents and Chemotherapy|August 3, 2022
Safety and Pharmacokinetics of Taniborbactam (VNRX-5133) with Cefepime in Subjects with Various Degrees of Renal ImpairmentJames A Dowell, Thomas C Marbury, William B Smith, et al.
Journal of Proteome Research|June 30, 2015
Quantification of SAHA-Dependent Changes in Histone Modifications Using Data-Independent Acquisition Mass SpectrometryKimberly A Krautkramer, Lukas Reiter, John M Denu, et al.
Journal of Neurochemistry|September 20, 2013
c-Jun N-terminal kinase regulates mGluR-dependent expression of post-synaptic FMRP target proteinsTravis L Schmit, James A Dowell, Margaret E Maes, et al.
Journal of Clinical Pharmacology|January 14, 2005
Assessment of the safety and pharmacokinetics of anidulafungin when administered with cyclosporineJames A Dowell, Martin Stogniew, David Krause, et al.
ACS Omega|February 8, 2021
Benchmarking Quantitative Performance in Label-Free ProteomicsJames A Dowell, Logan J Wright, Eric A Armstrong, et al.
Journal of Clinical Pharmacology|July 18, 2008
Pharmacokinetic-pharmacodynamic modeling of dalbavancin, a novel glycopeptide antibioticJames A Dowell, Beth P Goldstein, Mary Buckwalter, et al.
Pageof 4